Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Schlumberger, Citigroup, Berkshire Hathaway And More: CNBC's 'Final Trades'

Published 06/03/2024, 13:44
Updated 06/03/2024, 15:10
© Reuters.  Schlumberger, Citigroup, Berkshire Hathaway And More: CNBC's 'Final Trades'

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC’s "Halftime Report Final Trades," Shannon Saccocia of NB Private Wealth named iShares MSCI Japan ETF (NYSE: EWJ) (NASDAQ: GOOGL) as her final trade.

Sarat Sethi said Schlumberger Limited (NYSE: SLB) is very attractive at these levels.

On Jan. 30, Schlumberger reiterated the 2024 guidance despite Saudi Aramco’s decision on oil capacity. During its fourth-quarter earnings call, the company disclosed 2024 guidance of strong year-over-year revenue growth and continued margin expansion, leading to mid-teens growth in adjusted EBITDA.

Don’t forget to check out our premarket coverage here

Joshua Morgan Brown of Ritholtz Wealth Management picked Berkshire Hathaway Inc. (NYSE: BRK-B) (NYSE: BRK-A).

On Feb. 28, UBS analyst Brian Meredith maintained Berkshire Hathaway with a Buy and raised the price target from $435 to $477.

Jim Lebenthal of Cerity Partners named Citigroup Inc. (NYSE: C).

On Jan. 12, Citigroup reported a fourth-quarter 2023 revenue decline of 3% year-over-year to $17.44 billion, missing the consensus of $18.74 billion. Adjusted EPS of 84 cents beat the consensus of 81 cents. Citigroup expected to cut 20,000 jobs in the “medium term” as it reported its worst quarter for 15 years, the Financial Times reported.

Price Action:

  • iShares MSCI Japan ETF gained 0.5% on Tuesday.
  • SLB shares rose 0.5% to close at $49.66 during Tuesday’s session.
  • Shares of Berkshire Hathaway fell 0.7% to close at $400.74 on Tuesday.
  • Citigroup shares rose 0.2% to settle at $56.26 on Tuesday.

Image: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.